Kliničke studije za Melanom u državi Oklahoma
14 studija za Melanom traži sudionike na lokacijama u državi Oklahoma.
Gradovi u državi Oklahoma
Službeni tekst studije (engleski)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Hospital Oklahoma City, Oklahoma City
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- University of Oklahoma Health Sciences Center, Oklahoma City
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT05136196A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06246916Pan-tumor MRD Study
- Oklahoma Cancer Specialists and Research Institute (OCSRI), Tulsa
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06605404Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- University of Oklahoma Health Sciences Center, Oklahoma City
U tijeku regrutacijaFaza 3
Od 75 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07068074A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT04511013Project: Every Child for Younger Patients With Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
- Saint Francis Children's Hospital, Tulsa
U tijeku regrutacijaOpažajna studija
Do 25 godina · Oba spola · Ažurirano 25. kol 2026. · NCT02402244Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Mercy Hospital - OKC, Oklahoma City
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 29. lip 2026. · NCT07327489Neoadjuvant Darovasertib in Primary Uveal Melanoma
- Retina Consultants of Oklahoma, Oklahoma City
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 6. svi 2026. · NCT07015190Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Mercy Hospital Oklahoma City, Oklahoma City
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 17. ožu 2026. · NCT06418204Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- OU Health Stephenson Cancer Center, Oklahoma City
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. velj 2026. · NCT05549297SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Tulsa
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774BostonGene and Exigent Genomic INsight Study
- Oklahoma Cancer Specialists and Research Institute, Tulsa
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 17. velj 2025. · NCT06272864Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- OUHSC Stephenson Cancer Center, Oklahoma City
- Mercy Health Center - Oncology Hematology, Oklahoma City
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 27. stu 2024. · NCT03860883Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.